Gorillacillin and the Tragedy of the Commons
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
This weekend, I had the pleasure of being a guest on Peoples Pharmacy, a great public radio show that hails out of Durham NC. We had a far ranging, rapidly shifting conversation about lots of things. Check it out if you are interested. The show even gave me a chance to learn a new skill. …
How is a physician supposed to know which medicine is most affordable under which insurance plan?
Fortunately, there are tools coming into use designed to help clinicians figure out patient-specific costs of any medication they prescribe. The tools (jargon alert!) are called RTBTs, for real-time benefit tools.
Dr. Smith Townsend knelt on the filthy train station floor, the patient lying in front of him with a bullet wound in his back. The patient was clinically stable for the moment, so Townsend turned his attention to the wound, convinced a quick removal of the bullet would offer his patient the best chance of…
A quick quiz before we start today’s lesson. What do we call a tree that grows from acorns? What do we call a funny story? What sound does a frog make? What is another word for a cape? What do we call the white part of an egg? On that last question, were you tempted…
In research I have had the pleasure of conducting with Darin Zahurenic, we are starting to find concerning data about the variability in how neurologists and neurosurgeons treat people who have strokes caused by bleeding in their brains – or what doctors call intracerebral hemorrhage. Darin recently presented some of this research at a medical…
Nine to twelve years. That’s about how long most drug companies have to make serious money on new products before their patent protection ends. Then, generic companies enter the fray and prices, typically, plummet. Yet, two decades after coming to market, Herceptin (a drug used to treat breast and stomach cancer) was still priced at…